Daniel R. Chevallard - Nov 7, 2025 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Chief Financial Officer
Signature
/s/ Daniel R. Chevallard
Stock symbol
LENZ
Transactions as of
Nov 7, 2025
Transactions value $
$50,017
Form type
4
Date filed
11/7/2025, 07:42 PM
Previous filing
Jan 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chevallard Daniel R. Chief Financial Officer C/O LENZ THERAPEUTICS, INC., 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH /s/ Daniel R. Chevallard 2025-11-07 0001706176

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LENZ Common Stock Purchase $454 +20 +0.63% $22.71 3.21K Nov 7, 2025 Direct
transaction LENZ Common Stock Purchase $49.6K +2.18K +67.89% $22.76 5.39K Nov 7, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.